Latest news
Psoriasiform Dermatitis Following JAK Inhibitor Therapy for Hidradenitis Suppurativa and Crohn’s Disease - CureusCureus · Wed, 05 Aug 2026 16:26:24 GMTExpedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD - General AtlanticGeneral Atlantic · Wed, 05 Aug 2026 12:00:31 GMTInhibitor Therapeutics (INTI) holder makes 3.2M-share gift - Stock TitanStock Titan · Wed, 05 Aug 2026 06:23:20 GMTDirector Ronald Osman gets 50,000-share award from Inhibitor Therapeutics (INTI) - Stock TitanStock Titan · Tue, 04 Aug 2026 17:33:56 GMTInhibitor Therapeutics (INTI) awards 50,000 restricted shares to director - Stock TitanStock Titan · Tue, 04 Aug 2026 16:19:28 GMTDirector at Inhibitor Therapeutics (INTI) receives 50K restricted shares - Stock TitanStock Titan · Tue, 04 Aug 2026 16:15:50 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 13:15:00 GMTPROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREA - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:30:00 GMT